PT Darya-Varia Laboratoria Tbk (DVLA) Stock Price & Analysis
DVLA Stock Chart & Stats
- Day’s Range
- IDR 1,570.00 - IDR 1,570.00
- 52-Week Range
- IDR 1,420.00 - IDR 1,695.00
- Previous Close
- IDR 1,570.00
- Volume
- N/A
- Average Volume (3M)
- 27.87K
- Market Cap
- IDR 1.76T
- Enterprise Value
- IDR 1.45T
- Total Cash (Recent Filing)
- IDR 324.34B
- Total Debt (Recent Filing)
- IDR 75.00M
- Price to Earnings (P/E)
- 12.4
- Beta
- 0.32
- Next Earnings
- Apr 01, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Jun 30, 2026
- Dividend Yield
- 6.69%
DVLA FAQ
What was PT Darya-Varia Laboratoria Tbk’s price range in the past 12 months?
What is PT Darya-Varia Laboratoria Tbk’s market cap?
When is PT Darya-Varia Laboratoria Tbk’s upcoming earnings report date?
How were PT Darya-Varia Laboratoria Tbk’s earnings last quarter?
Is PT Darya-Varia Laboratoria Tbk overvalued?
Does PT Darya-Varia Laboratoria Tbk pay dividends?
What is PT Darya-Varia Laboratoria Tbk’s EPS estimate?
How many shares outstanding does PT Darya-Varia Laboratoria Tbk have?
What happened to PT Darya-Varia Laboratoria Tbk’s price movement after its last earnings report?
Which hedge fund is a major shareholder of PT Darya-Varia Laboratoria Tbk?
What is the TipRanks Smart Score and how is it calculated?
Company Description
PT Darya-Varia Laboratoria Tbk
PT Darya-Varia Laboratoria Tbk is an Indonesian enterprise dedicated to the production and commercialization of pharmaceutical goods and cosmetic items. Its operations are organized into three primary divisions: prescription medications, consumer health products, and services for export and contract manufacturing. The company offers a comprehensive selection of both prescribed and over-the-counter health solutions, addressing categories like antibiotics, antiparasitics, antiseptics, antifungals, treatments for coughs and colds, cardiovascular conditions, central nervous system disorders, gastrointestinal and liver ailments, somatic issues, vitamins and dietary supplements, women's health, ear care, and dermatological concerns. Beyond its domestic activities, the firm also distributes its products internationally to nations such as Malaysia, Myanmar, the Philippines, Singapore, Vietnam, and Mongolia. Established in 1976, PT Darya-Varia Laboratoria Tbk is headquartered in Jakarta, Indonesia, and functions as a subsidiary of Blue Sphere Singapore Pte. Ltd.
- Sector
- General
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ian Martin Wibawa Kloer
- Employees
- 1,344
- Website
- www.darya-varia.com
- Address
- Tower C, Jakarta, JK, 12430, ID
PT Darya-Varia Laboratoria Tbk (DVLA) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 12 | 4 | 6 |
| Technical Analysis | 2 | 4 | 4 |
| Moving Averages | 10 | 0 | 2 |

